Abbvie Inc [NYSE: ABBV] slipped around -7.67 points on Friday, while shares priced at $159.62 at the close of the session, down -4.58%. Compared to the average trading volume of 5.62M shares, ABBV reached a trading volume of 10659376 in the most recent trading day,
Abbvie Inc [NYSE: ABBV] surged by $1.48 during the normal trading session on while it closed the day at $167.89. Abbvie Inc stock has also gained 3.85% of its value over the past 7 days. However, ABBV stock has inclined by 1.51% in the 3
Abbvie Inc [NYSE: ABBV] price surged by 0.54 percent to reach at $0.87. The one-year ABBV stock forecast points to a potential upside of 11.8. The average equity rating for ABBV stock is currently 1.97, trading closer to a bullish pattern in the stock market.
Abbvie Inc [NYSE: ABBV] gained 0.20% or 0.34 points to close at $170.14 with a heavy trading volume of 5932915 shares. The company report on April 9, 2024 at 8:00 AM that SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne. From
Abbvie Inc [NYSE: ABBV] loss -0.04% or -0.07 points to close at $180.69 with a heavy trading volume of 4523411 shares. The company report on April 1, 2024 at 7:50 AM that NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7%
Abbvie Inc [NYSE: ABBV] stock went on an upward path that rose over 0.65% on Wednesday, amounting to a one-week price increase of more than 2.31%. The company report on March 25, 2024 at 11:00 AM that Allergan Aesthetics Launches “Moving the Needle on Ethics”
Abbvie Inc [NYSE: ABBV] closed the trading session at $177.88. The company report on March 7, 2024 at 8:00 AM that AbbVie to Present at the Barclays 26th Annual Global Healthcare Conference. AbbVie (NYSE: ABBV) will participate in the Barclays 26th Annual Global Healthcare Conference
Abbvie Inc [NYSE: ABBV] gained 0.72% on the last trading session, reaching $180.92 price per share at the time. The company report on March 7, 2024 at 8:00 AM that AbbVie to Present at the Barclays 26th Annual Global Healthcare Conference. AbbVie (NYSE: ABBV) will
Abbvie Inc [NYSE: ABBV] traded at a high on Tuesday, posting a 1.19 gain after which it closed the day’ session at $179.16. The company report on March 5, 2024 at 8:00 AM that JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval. THE
Abbvie Inc [NYSE: ABBV] plunged by -$0.99 during the normal trading session on while it closed the day at $178.00. The company report on February 28, 2024 at 12:05 AM that AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the
© 2024, Powered by Smart TechOne
